Industry News
Biotechnology Industry News
Ixaka’s cell therapy clears early phase 3 data review
Ixaka’s cell therapy clears early phase 3 data review ntaylor Fri, 09/10/2021 - 08:35
Vor’s cancer cell therapy gets on FDA fast track ahead of 2022 data drop
Vor’s cancer cell therapy gets on FDA fast track ahead of 2022 data drop ntaylor Fri, 09/10/2021 - 06:10
Researchers pinpoint autoimmune antibodies that may predict COVID-19 severity
Researchers pinpoint autoimmune antibodies that may predict COVID-19 severity klahucik Thu, 09/09/2021 - 15:37
Cardiff reveals early data on challenger to Amgen’s KRAS crown
Cardiff reveals early data on challenger to Amgen's KRAS crown aarmstrong Thu, 09/09/2021 - 10:20
Obsidian bags $115M to untether cell therapy from toxic sidekick
Obsidian bags $115M to untether cell therapy from toxic sidekick ntaylor Thu, 09/09/2021 - 06:54
Lilly-backed Lycia Therapeutics nabs $70M round for its protein degradation tech
Lilly-backed Lycia Therapeutics nabs $70M round for its protein degradation tech badams Thu, 09/09/2021 - 06:49
Sanofi’s BTK inhibitor flunks phase 3 autoimmune trial, delivering blow to $3.7B biotech bet
Sanofi's BTK inhibitor flunks phase 3 autoimmune trial, delivering blow to $3.7B biotech bet ntaylor Thu, 09/09/2021 - 05:21
FDA slams the door in Humanigen’s face, rejects emergency use green light, wants more data
FDA slams the door in Humanigen’s face, rejects emergency use green light, wants more data badams Thu, 09/09/2021 - 05:20
Science 37 teams up with Roche’s Foundation Medicine to boost home-based oncology trials
Science 37 teams up with Roche’s Foundation Medicine to boost home-based oncology trials badams Thu, 09/09/2021 - 04:48
As gene therapy safety faces scrutiny, Broad Institute proposes a safer and more efficient delivery tool
As gene therapy safety faces scrutiny, Broad Institute proposes a safer and more efficient delivery tool aliu Wed, 09/08/2021 - 13:41
Lexeo keeps foot on the gas pedal with $100M financing to follow up Stelios buy
Lexeo keeps foot on the gas pedal with $100M financing to follow up Stelios buy aarmstrong Wed, 09/08/2021 - 13:07
BioNTech reports promising data on mRNA cocktail in mouse models of colon cancer and melanoma
BioNTech reports promising data on mRNA cocktail in mouse models of colon cancer and melanoma arlene.weintraub Wed, 09/08/2021 - 11:14
Catabasis Pharmaceuticals no more: Meet Astria Therapeutics, hoping to be a phoenix from the flames
Catabasis Pharmaceuticals no more: Meet Astria Therapeutics, hoping to be a phoenix from the flames badams Wed, 09/08/2021 - 08:26
Insilico puts undruggable cancer targets in its crosshairs with Huadong alliance
Insilico puts undruggable cancer targets in its crosshairs with Huadong alliance ntaylor Wed, 09/08/2021 - 08:26
Goodbye PAM: Merck KGaA sells clinical-phase cancer prospect to French startup
Goodbye PAM: Merck KGaA sells clinical-phase cancer prospect to French startup ntaylor Wed, 09/08/2021 - 06:17
Eli Lilly follows up MiNA pact with a 2nd $1B-plus RNA collab, this time with ProQR
Eli Lilly follows up MiNA pact with a 2nd $1B-plus RNA collab, this time with ProQR badams Wed, 09/08/2021 - 03:31
Exelixis stunned by death of Chief Medical Officer Schwab, sales lead Berndt
Exelixis stunned by death of Chief Medical Officer Schwab, sales lead Berndt badams Tue, 09/07/2021 - 09:41
Amgen, AstraZeneca dig into data from phase 3 asthma trial, emerging with evidence of efficacy in hard-to-treat subgroup
Amgen, AstraZeneca dig into data from phase 3 asthma trial, emerging with evidence of efficacy in hard-to-treat subgroup ntaylor Tue, 09/07/2021 - 08:14
FDA slaps clinical hold on BioMarin gene therapy trial after tumors seen in mice
FDA slaps clinical hold on BioMarin gene therapy trial after tumors seen in mice ntaylor Tue, 09/07/2021 - 05:29
Roche, hoping to move on from recent failure, pens $190M NeuExcell Huntington’s disease pact
Roche, hoping to move on from recent failure, pens $190M NeuExcell Huntington's disease pact badams Tue, 09/07/2021 - 03:29